Woman's own immune system has possibly cured her of HIV
NBC News, November 2021
For the second time in the four-decade history of the HIV epidemic, researchers have documented a case of an individual's own immune system curing them of HIV. Even after scanning over 1 billion cells from the 30-year-old mother from Argentina with highly sophisticated and sensitive tests, scientists could find no viable viral DNA in her body.
NBC News, November 2021
For the second time in the four-decade history of the HIV epidemic, researchers have documented a case of an individual's own immune system curing them of HIV. Even after scanning over 1 billion cells from the 30-year-old mother from Argentina with highly sophisticated and sensitive tests, scientists could find no viable viral DNA in her body.
Covid antibody drugs could protect people with weak immune systems against Covid
NBC News, November 2021
If the FDA grants emergency authorization to monoclonal antibodies as pre-exposure prophylaxis (PrEP) against Covid-19, how accessible will this preventive therapy be for immunocompromised people? Demand for the antibodies as treatment has fallen. But health care providers are struggling with staffing concerns, which could affect their capacity to provide PrEP.
NBC News, November 2021
If the FDA grants emergency authorization to monoclonal antibodies as pre-exposure prophylaxis (PrEP) against Covid-19, how accessible will this preventive therapy be for immunocompromised people? Demand for the antibodies as treatment has fallen. But health care providers are struggling with staffing concerns, which could affect their capacity to provide PrEP.
FDA authorizes Covid antibody treatment as preventive after exposure
NBC News, August 2021
The FDA has approved Regeneron's monoclonal antibody cocktail, REGEN-COV, for use as post-exposure prevention among unvaccinated and immunocompromised people at high risk of severe Covid-19. They must have been in recent close contact with someone who tested positive for SARS-CoV-2.
NBC News, August 2021
The FDA has approved Regeneron's monoclonal antibody cocktail, REGEN-COV, for use as post-exposure prevention among unvaccinated and immunocompromised people at high risk of severe Covid-19. They must have been in recent close contact with someone who tested positive for SARS-CoV-2.
Long-acting HIV-prevention drugs may be key to beating the epidemic in the U.S.
NBC News, July 2021
Dosed no more frequently than monthly, these experimental drugs offer potential solutions to a problem that has long frustrated the HIV fight: that many at-risk people find adhering to a daily preventive medication too burdensome. But will a critical mass of Black and Latino gay and bisexual men, who comprise nearly half of new HIV diagnoses, end up taking these drugs?
NBC News, July 2021
Dosed no more frequently than monthly, these experimental drugs offer potential solutions to a problem that has long frustrated the HIV fight: that many at-risk people find adhering to a daily preventive medication too burdensome. But will a critical mass of Black and Latino gay and bisexual men, who comprise nearly half of new HIV diagnoses, end up taking these drugs?
PrEP, the HIV prevention pill, must now be totally free under almost all insurance plans
NBC News, July 2021
In a move hailed as potentially transformative by HIV advocates, the federal government has issued a guidance instructing almost all insurance plans to stop charging all out-of-pocket fees for the HIV prevention pill, known as PrEP. This includes the medication itself and, crucially, the quarterly clinic visits and lab tests required to maintain the prescription.
NBC News, July 2021
In a move hailed as potentially transformative by HIV advocates, the federal government has issued a guidance instructing almost all insurance plans to stop charging all out-of-pocket fees for the HIV prevention pill, known as PrEP. This includes the medication itself and, crucially, the quarterly clinic visits and lab tests required to maintain the prescription.
'This will shut us down': HIV prevention clinics brace for Gilead reimbursement cuts
NBC News, July 2021
HIV prevention clinics are facing a fiscal crisis owing to the vagaries of an arcane federal drug pricing law, with a bare minimum of $100 million annually expected to drain from the nonprofits starting in 2022. This devastating loss of funds, which is expected to shut down some clinics, comes just as the federal government has ramped up spending in an effort to essentially end the HIV epidemic by 2030.
NBC News, July 2021
HIV prevention clinics are facing a fiscal crisis owing to the vagaries of an arcane federal drug pricing law, with a bare minimum of $100 million annually expected to drain from the nonprofits starting in 2022. This devastating loss of funds, which is expected to shut down some clinics, comes just as the federal government has ramped up spending in an effort to essentially end the HIV epidemic by 2030.
As Meth Overdoses Soar, Scientists Develop First Regimen to Treat Addiction to the Drug
NBC News, February 2021
Just as the National Institute on Drug Abuse has issued a report detailing the U.S.'s soaring rate of overdose deaths tied to meth, a national research team has reached a milestone by developing the first safe and efficacious medication-based treatment for addiction to the often ruinous stimulant.
NBC News, February 2021
Just as the National Institute on Drug Abuse has issued a report detailing the U.S.'s soaring rate of overdose deaths tied to meth, a national research team has reached a milestone by developing the first safe and efficacious medication-based treatment for addiction to the often ruinous stimulant.